By
Voxelcare, a leading global provider of technology systems for producing custom foot orthotics, announces a new partnership with Axon Partners Group, who comes in as a minority investor to support the company’s global expansion plans.
Founded in Elche (Alicante), although with part of its operations in Amsterdam, Voxelcare commercialises an end-to-end solution for custom foot orthotics (insoles) manufacturing, allowing footcare professionals to diagnose, design and produce custom foot orthotics in-house. The company was founded by Michael Lampert, current CEO and Santiago Ledesma and currently employs 47 people. With sales in more than 50 countries, Voxelcare has achieved strong success since its inception and is currently positioned as a global referent in high-precision technology for the foot orthotic market.
Voxelcare has developed a completely proprietary, cloud-based, 3D printing technology, which allows footcare specialists such as podiatrists, orthopaedic technicians and footcare retailers to produce a pair of custom orthotic insoles at a point of sale in less than one hour. Voxelcare has managed to develop its state-of-the-art technology without external investment to date. With Axon’s entry, the company plans to fulfil its vision of bringing custom footcare worldwide.
This investment, closed at the end of 2024, marks Axon’s fifth deal this year under its Growth Equity strategy, aligning with its investment thesis of backing innovative companies with exceptional founders, high growth, and an efficient use of capital. The investment comes from the Axon Innovation Growth Fund, a vehicle focused on European scale-up companies, which has also invested in firms such as Metricool, Embention, and Dogfy Diet.
Michael Lampert, Voxelcare CEO, highlights: We are very proud of our new partnership with Axon. Today, while foot orthotic insoles are in high demand, only a small number of people have convenient access to them. With Axon, we have found the right partner that shares our vision and ambition to continue developing the best possible footcare technology and making it available, accessible, and affordable all over the world. The deal with Axon kicks off the next stage of our company journey and allows us to deliver on our ambitious future growth plans.
César Gimeno Le Paih, Principal at Axon Partners comments: We are delighted to be partnering with Voxelcare and Michael’s team to support the company’s journey in becoming the largest global provider of tech solutions for the custom foot orthotic market. We are confident our experience investing in fast-growing technology companies will help Voxelcare reach its goals
